SG11201903329WA - Method for preparing electrocompetent yeast cells, and method for using said cells - Google Patents
Method for preparing electrocompetent yeast cells, and method for using said cellsInfo
- Publication number
- SG11201903329WA SG11201903329WA SG11201903329WA SG11201903329WA SG11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- cells
- yeast
- pct
- boehmert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1#1110111101110101011111 3E1 0 011101111110111 0011101111111011 OEN Organization 0 International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/091396 Al 24 May 2018 (24.05.2018) W I PO I PCT (51) International Patent Classification: C12N 15/90 (2006.01) Cl 2N 13/00 (2006.01) (21) International Application Number: PCT/EP2017/079011 (22) International Filing Date: 13 November 2017 (13.11.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 10 2016 121 899.5 15 November 2016 (15.11.2016) DE (71) Applicant: IMMATICS BIOTECHNOLOGIES GMBH [DE/DE]; Paul-Ehrlich-StraBe 15, 72076 Tiibingen (DE). (72) Inventors: BUNK, Sebastian; Gertrud-Baeumer-Str. 19/1, 72074 Tiibingen (DE). MAURER, Dominik; Fleinerweg 7, 72116 Moessingen (DE). UNVERDORBEN, Felix; Mohringer Strasse 157, 70199 Stuttgart (DE). Agent: BOEHMERT & BOEHMERT; Krauss, Jan B., Pettenkoferstrasse 22, 80336 Munich (DE). (74) = Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (81) = _ = DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, = = — = OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = Designated States (unless otherwise indicated, for every (84) kind of regional protection available): ARIPO (BW, GH, = _ _ GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, = UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, = TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, = EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, = MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, — TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). = — Published: ,- 1 — with international search report (Art. 21(3)) 01 M 1-1 01 O_ 0 (54) Title: METHOD FOR PREPARING ELECTROCOMPETENT YEAST CELLS, AND METHOD FOR USING SAID CELLS 1-1 0 (57) : The present invention relates to improved yeast transformation of yeast cells and yeast cell libraries transformed thereby. ei More specifically, the present invention relates to the transformation of yeast by electroporation.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102016121899.5A DE102016121899A1 (en) | 2016-11-15 | 2016-11-15 | Process for the preparation of electrocompetent yeast cells and methods of using these cells |
| PCT/EP2017/079011 WO2018091396A1 (en) | 2016-11-15 | 2017-11-13 | Method for preparing electrocompetent yeast cells, and method for using said cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201903329WA true SG11201903329WA (en) | 2019-05-30 |
Family
ID=60484335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201903329WA SG11201903329WA (en) | 2016-11-15 | 2017-11-13 | Method for preparing electrocompetent yeast cells, and method for using said cells |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US10683495B2 (en) |
| EP (1) | EP3541947B1 (en) |
| JP (2) | JP7133226B2 (en) |
| KR (1) | KR102194520B1 (en) |
| CN (1) | CN109983130B (en) |
| AR (1) | AR110087A1 (en) |
| AU (1) | AU2017360666C1 (en) |
| BR (1) | BR112019008385A2 (en) |
| CA (1) | CA3043953A1 (en) |
| DE (1) | DE102016121899A1 (en) |
| DK (1) | DK3541947T3 (en) |
| EA (1) | EA201990758A1 (en) |
| ES (1) | ES2952039T3 (en) |
| IL (1) | IL266538A (en) |
| MA (1) | MA46835A (en) |
| MX (1) | MX2019005622A (en) |
| MY (1) | MY191776A (en) |
| NZ (1) | NZ752651A (en) |
| PH (1) | PH12019501001A1 (en) |
| SG (1) | SG11201903329WA (en) |
| TW (1) | TWI720268B (en) |
| UA (1) | UA125076C2 (en) |
| WO (1) | WO2018091396A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017125888A1 (en) | 2017-11-06 | 2019-05-23 | Immatics Biotechnologies Gmbh | New engineered T cell receptors and their use in immunotherapy |
| ES2941965T3 (en) | 2017-11-06 | 2023-05-29 | Immatics Biotechnologies Gmbh | New engineered T cell receptors and immunotherapies based on their use |
| DE102019108125B4 (en) | 2019-03-28 | 2022-02-03 | Immatics US, Inc. | CD28 T-CELL CULTURES, COMPOSITIONS AND METHODS OF USE |
| US20200297768A1 (en) | 2019-03-19 | 2020-09-24 | Immatics US, Inc. | Cd28 t cell cultures, compositions, and methods of using thereof |
| DE102019121007A1 (en) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Antigen binding proteins that specifically bind to MAGE-A |
| US20230132241A1 (en) | 2020-01-15 | 2023-04-27 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
| BR112023022765A2 (en) | 2021-05-05 | 2024-01-02 | Immatics Biotechnologies Gmbh | ANTIGEN-BINDING PROTEINS THAT SPECIFICALLY BIND PRAME |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0580737B1 (en) | 1991-04-10 | 2004-06-16 | The Scripps Research Institute | Heterodimeric receptor libraries using phagemids |
| CA2697282C (en) | 2007-08-20 | 2018-02-13 | Nextera As | Pvii phage display |
| SG188846A1 (en) * | 2008-03-03 | 2013-04-30 | Abbott Lab | Methods for transforming yeast |
| WO2009114096A1 (en) | 2008-03-13 | 2009-09-17 | Cardiac Pacemakers, Inc. | Systems and devices for modulating autonomic tone |
| MX2013000989A (en) | 2010-07-28 | 2013-03-05 | Immunocore Ltd | T cell receptors. |
| EP3237908A1 (en) * | 2014-12-22 | 2017-11-01 | Universität Zürich | Directed evolution of membrane proteins in eukaryotic cells with a cell wall |
-
2016
- 2016-11-15 DE DE102016121899.5A patent/DE102016121899A1/en active Pending
-
2017
- 2017-11-13 WO PCT/EP2017/079011 patent/WO2018091396A1/en unknown
- 2017-11-13 BR BR112019008385A patent/BR112019008385A2/en unknown
- 2017-11-13 EA EA201990758A patent/EA201990758A1/en unknown
- 2017-11-13 NZ NZ752651A patent/NZ752651A/en unknown
- 2017-11-13 MX MX2019005622A patent/MX2019005622A/en unknown
- 2017-11-13 KR KR1020197013641A patent/KR102194520B1/en active IP Right Grant
- 2017-11-13 CN CN201780069926.8A patent/CN109983130B/en active Active
- 2017-11-13 MY MYPI2019002307A patent/MY191776A/en unknown
- 2017-11-13 MA MA046835A patent/MA46835A/en unknown
- 2017-11-13 DK DK17805126.4T patent/DK3541947T3/en active
- 2017-11-13 SG SG11201903329WA patent/SG11201903329WA/en unknown
- 2017-11-13 ES ES17805126T patent/ES2952039T3/en active Active
- 2017-11-13 UA UAA201904554A patent/UA125076C2/en unknown
- 2017-11-13 EP EP17805126.4A patent/EP3541947B1/en active Active
- 2017-11-13 CA CA3043953A patent/CA3043953A1/en active Pending
- 2017-11-13 AU AU2017360666A patent/AU2017360666C1/en active Active
- 2017-11-13 JP JP2019521754A patent/JP7133226B2/en active Active
- 2017-11-15 US US15/813,879 patent/US10683495B2/en active Active
- 2017-11-15 TW TW106139472A patent/TWI720268B/en active
- 2017-11-15 AR ARP170103182A patent/AR110087A1/en unknown
-
2019
- 2019-05-07 PH PH12019501001A patent/PH12019501001A1/en unknown
- 2019-05-08 IL IL266538A patent/IL266538A/en unknown
-
2020
- 2020-05-08 US US16/869,784 patent/US11104894B2/en active Active
-
2021
- 2021-07-29 US US17/389,061 patent/US20210355478A1/en active Pending
-
2022
- 2022-06-17 JP JP2022097799A patent/JP2022130501A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201903329WA (en) | Method for preparing electrocompetent yeast cells, and method for using said cells | |
| SG11201811048UA (en) | Single-cell transcript sequencing | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
| SG11201810605UA (en) | Selectively altering microbiota for immune modulation | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201805950UA (en) | Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201908567UA (en) | Modified cyclic dinucleotide compounds | |
| SG11201907857RA (en) | Edible and biodegradable utensils | |
| SG11201900772YA (en) | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors | |
| SG11201811336TA (en) | Method for producing an electrode catalyst from a perovskite metal oxide | |
| SG11201407774XA (en) | Conversion of biomass | |
| SG11201901494UA (en) | Acid-alpha glucosidase variants and uses thereof | |
| SG11201909087PA (en) | Perfusion medium | |
| SG11201809530PA (en) | Method for recovery of phosphate | |
| SG11201808762XA (en) | Diagnostic methods for patient specific therapeutic decision making in cancer care | |
| SG11201904535VA (en) | Prevention and treatment of bone and cartilage damage or disease | |
| SG11201809594WA (en) | Nicotine particles and compositions | |
| SG11201804916PA (en) | Three-dimensional polymer networks with channels situated therein | |
| SG11201909419XA (en) | Hydrogel for cell culture and biomedical applications | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201407800SA (en) | Selective binding of biological targets to solid phase ureides | |
| SG11201901438VA (en) | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate |